-transparent.png){kind=logo}
Adinazolam (ADI) is a new benzodiazepine with anxiolytic and antidepressant properties. To assess its effects on the acute stress response, rats were given a single intraperitoneal injection of 2.5 or 5.0 mg/kg of ADI and stressed for 1 hr by restraint. Neither dose of ADI had any effect on heart rate, blood pressure or norepinephrine (NE) and epinephrine (EP) in plasma in the resting rats. In the stressed animal, 2.5 and 5.0 mg/kg of ADI did not affect stress-induced increases in heart rate or blood pressure but both significantly reduced the stress-induced increases in plasma NE and EP. During certain stressful experiences in patients with abnormally-increased sympathetic drive, ADI may be therapeutically useful in reducing high levels of catecholamines.
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
October 1989,
Pharmacology, biochemistry, and behavior,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
July 1989,
The Journal of pharmacology and experimental therapeutics,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
June 1987,
Life sciences,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
June 1990,
Anasthesie, Intensivtherapie, Notfallmedizin,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
September 1991,
Clinical autonomic research : official journal of the Clinical Autonomic Research Society,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
September 1979,
The American journal of physiology,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
January 1988,
Proceedings of the Western Pharmacology Society,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
April 2003,
Naunyn-Schmiedeberg's archives of pharmacology,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
October 1983,
General and comparative endocrinology,
M J Krieman, and
D M Hershock, and
I J Greenberg, and
W H Vogel
January 1996,
Fundamental & clinical pharmacology,
